Clinical Trials Logo
  1. Home
  2. Social Cognition
  3. NCT05320991

Effects of Ketamine on Mentalizing and Metacognition in Healthy Volunteers — METAKETAII  

Social Cognition Clinical Trial

Official title:
A Randomized Control Trial Employing fMRI to Investigate the Effects of Ketamine on Mentalizing and Metacognition in Healthy Volunteers

Clinical Trial Summary

Antipsychotic medication shows generally good effect sizes when looking at reduction of positive psychotic symptoms of schizophrenia, such as paranoia or delusion. However, social functioning often remains deficient in patients, meaning dopamine-receptor antagonists are not sufficient in treatment of people with schizophrenia. A naturalistic video-based paradigm, named MASC has been used in the past to model over- and undermentalizing in patients with autism spectrum disorder and schizophrenia, since deficits in mentalizing can be explained by either overinterpreting a social situation (e.g. paranoid thoughts about intentions of others towards self) or by lacking the skill to read intentions of others. To find out whether experimental manipulation via a non-competetive N-methyl-D-aspartate antagonist can induce difficulties with social cognition similar to those observed in people with schizophrenia, the investigators will conduct a RCT applying either ketamine or a placebo intravenously while participants are completing the above mentioned mentalizing task in the fMRI-scanner.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05320991
Study type Interventional
Source University Hospital, Bonn
Contact
Status Completed
Phase Phase 4
Start date June 15, 2019
Completion date September 27, 2020
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04406675 - Social Cognition in Patients With Amyotrophic Lateral Sclerosis N/A
Completed NCT02566356 - Adult Study Oxytocin - fMRI Early Phase 1
Active, not recruiting NCT00747396 - The Bucharest Early Intervention Project N/A
Completed NCT02228031 - Oxytocin, Emotions and Mirror Neurons Early Phase 1
Completed NCT02567032 - Adult Study Oxytocin - Behavioral Early Phase 1
Recruiting NCT03035669 - Effects of Mindfulness Training on Emotion Regulation and Social Cognition. N/A
Completed NCT03775564 - Effectiveness of the RemedRugby Program N/A
Not yet recruiting NCT06213194 - The Effects of Executive Functions and Social Cognition on Mental Health N/A
Recruiting NCT05773872 - Evaluation of Social Cognition in Patient With Type 1 or Type 2 Narcolepsy Versus Patients With Idiopathic Hypersomnia N/A
Recruiting NCT01903915 - Social Dysfunction and Brain Dysfunction in Patients With Schizophrenia N/A
Recruiting NCT05194254 - MRI-Eye Tracking Pairing, a Tool for Assessing Social Cognition in Children With ASD N/A
Completed NCT00884897 - Oxytocin and Social Cognition in Schizophrenia Phase 2
Completed NCT03450356 - The German Version of the Awareness of Social Inference Test
Not yet recruiting NCT03812913 - Neuropsychological Assessment of Children and Adolescents With Turner Syndrome
Completed NCT02568709 - Oxytocin MEG Study Early Phase 1
Completed NCT02652013 - Evaluation and Neural Basis of Communication in Patients With Multiple Sclerosis N/A
Completed NCT05866328 - Online TP (Training Program) on SC (Social Cognition) for Schizophrenia N/A
Completed NCT01616407 - Effects of MDMA and Methylphenidate on Social Cognition Early Phase 1
Completed NCT01206842 - Social Cognition Training in Schizophrenia N/A
Completed NCT02577575 - Adult Oxytocin Study Early Phase 1